Clinical trial
Acetyl-L-Carnitine for the Treatment of NRTI-Associated Peripheral Neuropathy
NCT00050271 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00050271 |
|---|---|
| Title | Acetyl-L-Carnitine for the Treatment of NRTI-Associated Peripheral Neuropathy |
| Official title | An Open-Label, Dose-Escalation Pilot Study of Acetyl-L-Carnitine for the Treatment of Dideoxynucleoside-Associated Distal Symmetric Peripheral Neuropathy |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Collaborators | Neurologic AIDS Research Consortium (NARC) |
| Status | Completed |
| Study type | Interventional |
| Conditions | HIV Infections, Peripheral Nervous System Diseases |
| Intervention type | Drug |
| Interventions | Acetyl-L-carnitine |
| Enrollment | 27 |
| Completion | Jan 1, 2007 |
| First posted | Dec 4, 2002 |
| Last update posted | Nov 1, 2021 |
| Countries | Puerto Rico, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: